|
We asked 40 pharma leaders, Into which pharmerging market — aside from China and India — is your company most interested in expanding?
| Brazil |
37% |
| Turkey |
5% |
| Russia |
26% |
| Indonesia |
5% |
| Argentina |
5% |
| South Africa |
5% |
| Other |
17% |
 |
|
|
|
|
|
|
|
31 July, 2012
|
| In this Issue |
Patients Wade into the Pricing Debate
Patient groups are a growing force, not just in the debate around tactical areas of medical specialities, but also on the vital question of pricing and reimbursement rules. But will their voices be heard? Reflector reports. Read more... |
Innovative Contracting: What's the Verdict?
Industry is finding it harder to secure market access and payer uptake for new products. Innovative contracting may offer a solution. But is it working? Andrea Sobrio reports. More... |
GSK Goes DTC for London Olympics
It’s an unusual sight in the UK — a television commercial for a Big Pharma company. But among the cultural and commercial innovations being attributed to the London Olympic Games is GSK’s first UK consumer-facing corporate brand campaign. More... |
EC Offers Aid to Swedish AstraZeneca Workers
The European Commission is looking to provide Sweden with EUR4.3 million to help 700 workers affected by AstraZeneca job cuts to find new work. The proposal is currently awaiting approval from the European parliament and the EU’s Council of Ministers. More...
|
|
|
|
